Company intelligence / Profile preview

Maxxcare

Ho Chi Minh City, Vietnam

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Maxxcare is a leading pharmaceutical company in Vietnam and a key subsidiary of Zuellig Pharma. The company operates a WHO-GMP certified manufacturing facility and provides a comprehensive suite of commercial services, including marketing, sales, and distribution for multinational pharmaceutical partners. Maxxcare specializes in a wide range of therapeutic areas such as cardiovascular health, diabetes, and infectious diseases, serving as a vital link in the Vietnamese healthcare supply chain by both producing high-quality medicines and facilitating market access for international brands.

Therapeutic areas: EndocrinologyCardiovascularInfectious DiseasesPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

GSKMSDAstraZenecaPfizerNovartisSanofi

Beyond the preview

Go deeper on Maxxcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxxcare.

Explore the full profile